Jamieson Wellness Adjusts Valuation Amid Strong Financial Performance and Growth Metrics
Jamieson Wellness, Inc. has recently experienced a change in its valuation grade, now reflecting a more favorable financial standing. Key metrics include a P/E ratio of 31, a Price to Book Value of 2.58, and strong returns on capital and equity, alongside healthy sales growth and operating cash flow.
Jamieson Wellness, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in evaluation, reflecting notable shifts in its financial metrics. The company's valuation grade has transitioned from a classification of expensive to fair, indicating a more favorable assessment of its financial standing. Key metrics contributing to this revision include a P/E ratio of 31 and a Price to Book Value of 2.58, which align more closely with industry standards. Additionally, the company has demonstrated a robust return on capital employed (ROCE) of 10.49% and a return on equity (ROE) of 8.41%, showcasing effective management efficiency.
In terms of growth, Jamieson Wellness has reported a healthy annual net sales growth rate of 16.29%. The recent quarter ending June 2025 also highlighted strong operating cash flow, reaching CAD 61.58 million, alongside a notable dividend per share of CAD 3.74.
Overall, these underlying trends suggest a solid foundation for Jamieson Wellness, Inc. as it navigates the competitive landscape of its industry.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
